Form 4: Vicarious Surgical CEO Adam Sachs Sells Shares to Cover Tax Obligations

Vicarious Surgical CEO Adam Sachs sold 463 shares of Class A Common Stock at an average price of $13.5018 to cover tax obligations related to vesting restricted stock units.

Summary

• Adam Sachs, CEO of Vicarious Surgical Inc., sold 463 shares of Class A Common Stock on December 3, 2024.
• The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on June 2, 2023.
• The weighted average sale price was $13.5018 per share, with individual trades ranging from $12.60 to $14.66.
• Following the transaction, Sachs directly owns 53,781 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction for an executive to cover tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of 463 shares is relatively small compared to the total holdings of the CEO, which is 53,781 shares.
• Similar transactions are regularly reported by executives at other companies in the medical technology sector.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a small transaction by the CEO to cover tax obligations.

Key Dates

Keywords

Vicarious Surgical, Adam Sachs, stock sale, insider trading, Form 4, restricted stock units, tax obligations